Renovaro Biosciences Inc RENB

NAS: RENB | ISIN: US29350E1047 27/05/2025

0,320 USD (-2,08%)

(-2,08%) 27/05/2025

Grafiek Renovaro Biosciences Inc

Grafiek Renovaro Biosciences Inc

1 dag1d -2,08%
1 week1w 10,65%
1 maand1m -12,04%
3 maanden3m -67,43%
6 maanden6m -57,69%
1 jaar1j -78,23%
5 jaar5j -57,45%

Renovaro Biosciences Inc in het nieuws

Toon enkel gratis nieuws

4 april 2025 · Renovaro Provides Update to Definitive Agreement with Predictive Oncology · Persbericht

3 maart 2025 · Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology · Persbericht

26 februari 2025 · Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine · Persbericht

26 februari 2025 · Renovaro Announces $15 million in Equity Committed · Persbericht

7 januari 2025 · Renovaro Appoints Nathen Fuentes as Chief Financial Officer · Persbericht

7 januari 2025 · Renovaro Issues Shareholder Letter and Provides Corporate Update · Persbericht

6 januari 2025 · Renovaro to Acquire Predictive Oncology in All-Stock Transaction · Persbericht

30 december 2024 · Renovaro Inc. Appoints Maurice van Tilburg to Lead GEDi Cube BV · Persbericht

23 december 2024 · RenovaroCube Receives Approval of Lumina Project by the Eurostars Funding Program · Persbericht

20 december 2024 · Renovaro Regains Compliance with NASDAQ Listing Requirement · Persbericht

Profiel Renovaro Biosciences Inc

Website: enochianbio.com

Hoofdzetel: Los Angeles, California Verenigde Staten

Mijn selecties

Je selectie is nog leeg.

Voeg nu effecten toe